Literature DB >> 18191727

Identification of a distal tandem STAT6 element within the CCL17 locus.

Elisabeth Maier1, Gerald Wirnsberger, Jutta Horejs-Hoeck, Albert Duschl, Daniel Hebenstreit.   

Abstract

The CC chemokine ligand CCL17 is one of the major chemo-attractants for T(H)2 cells. Interleukin-4-induced activation of CCL17 expression was recently demonstrated to result from two STAT6 motifs in the proximal promoter. Here we provide evidence that a distal tandem STAT6 element further elevates expression from the CCL17 locus approximately twofold. This is demonstrated by reporter gene assays using different fragments of the CCL17 promoter and the region 2.5 kb upstream from the transcriptional start site. By electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation experiments, we show that STAT6 binds to the motifs in vitro and in vivo, respectively. Insertion of nucleotide exchanges into the STAT6 core motifs results in diminished promoter activation and abrogated STAT6 binding, as demonstrated by reporter gene and EMSA studies. Collectively these data reveal an additional element involved in the regulation of CCL17 expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18191727      PMCID: PMC2995035          DOI: 10.1016/j.humimm.2007.10.012

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  17 in total

1.  A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

Authors:  N C Andrews; D V Faller
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

2.  A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.

Authors:  C Vestergaard; K Bang; B Gesser; H Yoneyama; K Matsushima; C G Larsen
Journal:  J Invest Dermatol       Date:  2000-10       Impact factor: 8.551

3.  Set of optimized luciferase reporter gene plasmids compatible with widely used CAT vectors.

Authors:  J Altschmied; J Duschl
Journal:  Biotechniques       Date:  1997-09       Impact factor: 1.993

4.  Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity.

Authors:  M Goebeler; A Trautmann; A Voss; E V Bröcker; A Toksoy; R Gillitzer
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

5.  Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets.

Authors:  K J Clemetson; J M Clemetson; A E Proudfoot; C A Power; M Baggiolini; T N Wells
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

6.  Activation of eotaxin-3/CCLl26 gene expression in human dermal fibroblasts is mediated by STAT6.

Authors:  J Hoeck; M Woisetschläger
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

7.  Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309.

Authors:  M Inngjerdingen; B Damaj; A A Maghazachi
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

Review 8.  Chemoattractants and their receptors in homeostasis and inflammation.

Authors:  Federica Sallusto; Charles R Mackay
Journal:  Curr Opin Immunol       Date:  2004-12       Impact factor: 7.486

9.  Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.

Authors:  DirkJan Hijnen; Marjolein De Bruin-Weller; Bert Oosting; Cristina Lebre; Esther De Jong; Carla Bruijnzeel-Koomen; Edward Knol
Journal:  J Allergy Clin Immunol       Date:  2004-02       Impact factor: 10.793

10.  Enhancer-mediated control of macrophage-specific arginase I expression.

Authors:  Anne-Laure Pauleau; Robert Rutschman; Roland Lang; Alessandra Pernis; Stephanie S Watowich; Peter J Murray
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

View more
  6 in total

1.  IL-3 synergises with basophil-derived IL-4 and IL-13 to promote the alternative activation of human monocytes.

Authors:  Francesco Borriello; Michele Longo; Rosa Spinelli; Antonio Pecoraro; Francescopaolo Granata; Rosaria Ilaria Staiano; Stefania Loffredo; Giuseppe Spadaro; Francesco Beguinot; John Schroeder; Gianni Marone
Journal:  Eur J Immunol       Date:  2015-04-28       Impact factor: 5.532

2.  Inhibition of suppressive T cell factor 1 (TCF-1) isoforms in naive CD4+ T cells is mediated by IL-4/STAT6 signaling.

Authors:  Elisabeth Maier; Daniel Hebenstreit; Gernot Posselt; Peter Hammerl; Albert Duschl; Jutta Horejs-Hoeck
Journal:  J Biol Chem       Date:  2010-10-27       Impact factor: 5.157

Review 3.  STAT6-dependent and -independent mechanisms in Th2 polarization.

Authors:  Elisabeth Maier; Albert Duschl; Jutta Horejs-Hoeck
Journal:  Eur J Immunol       Date:  2012-10-08       Impact factor: 5.532

4.  CCL17/TARC and CCR4 expression in Merkel cell carcinoma.

Authors:  Kashif Rasheed; Ibrahim Abdulsalam; Silje Fismen; Øystein Grimstad; Baldur Sveinbjørnsson; Ugo Moens
Journal:  Oncotarget       Date:  2018-07-31

5.  The mediatory role of Majie cataplasm on inflammation of allergic asthma through transcription factors related to Th1 and Th2.

Authors:  Wenting Ji; Qianyi Zhang; Hanfen Shi; Ruijuan Dong; Dongyu Ge; Xin Du; Beida Ren; Xueqian Wang; Qingguo Wang
Journal:  Chin Med       Date:  2020-05-24       Impact factor: 5.455

6.  Human Th2 but not Th9 cells release IL-31 in a STAT6/NF-κB-dependent way.

Authors:  Elisabeth Maier; Dagmar Werner; Albert Duschl; Barbara Bohle; Jutta Horejs-Hoeck
Journal:  J Immunol       Date:  2014-06-18       Impact factor: 5.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.